Tenderwize
Retour à la recherche

Open-house rebate agreement for Paliperidone depot formulations

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Sep 03, 2027 · 370 days left·Open·Supplies·Framework
Inscrivez-vous pour sauvegarderOpen documents
Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Paliperidon, in 3-Monats-Depot-Darreichungsformen, ATC N05AX13

52/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

52 / 100

Complexité

48 / 100

Facteurs de risque

Submitting documents in the wrong DTVP area is explicitly prohibited; the notice says the contract documents must not b...

To obtain contract start on the next month’s first day, complete and correct documents must be received by the 3rd of t...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Oct 2027
  • Non-exclusive rebate agreement for pharmaceutical products: Paliperidone in 3-month depot dosage forms (ATC N05AX13).
  • Open-house model with identical, non-individually negotiable contract terms for all eligible pharmaceutical companies.
Afficher le résumé complet

This is an open-house supply arrangement by AOK Bayern for Paliperidone in 3-month depot formulations (ATC N05AX13). It is not a competitive award procedure in the usual sense: the buyer states that all interested pharmaceutical companies meeting the stated suitability requirement may join on identical, non-negotiable terms. The contract period runs from 01.11.2025 to 31.10.2027, with contract entry possible at any time until 03.09.2027. Submission is electronic via DTVP with a qualified electronic signature or by signed paper originals in duplicate; German language is required, and non-German documents must include a German translation.

Risques

Submitting documents in the wrong DTVP area is explicitly prohibited; the notice says the contract documents must not b...

To obtain contract start on the next month’s first day, complete and correct documents must be received by the 3rd of t...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • The contract and the annex 'Festlegung der vertragsgegenständlichen Arzneimittel' must be completed and signed.

Eligibility

  • Only pharmaceutical companies are eligible as potential contract partners.

Administrative

  • A signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit) must be submitted.

Acheteur

Localisation

München, DEU

Site web

www.aok.de

Profil acheteur

Ouvrir le profil

Identifiant

DE811695320

Activité

Health

Lots (1)

LOT-0001

Open-house rebate agreement for Paliperidone depot formulations

Supply arrangement for Paliperidone in 3-month depot dosage forms (ATC N05AX13). The lot is an open-house rebate agreement, not a selective tender. Contract terms are pre-set and non-negotiable. Performance is in Germany, Bavaria (DE212).

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE212, Germany

Durée

Oct 2025 - Oct 2027

Catégorie

Pharmaceutical products

Date limite

Deadline Sep 03, 2027

Détails de la procédure

Date de publication
14 Sep 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
602050-2025

Documents (2)

Document de consultation 1Portail de soumission 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30